Correlation Between Eliem Therapeutics and Clene
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Clene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Clene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Clene Inc, you can compare the effects of market volatilities on Eliem Therapeutics and Clene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Clene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Clene.
Diversification Opportunities for Eliem Therapeutics and Clene
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Eliem and Clene is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Clene Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clene Inc and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Clene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clene Inc has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Clene go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Clene
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Clene. But the stock apears to be less risky and, when comparing its historical volatility, Eliem Therapeutics is 1.35 times less risky than Clene. The stock trades about -0.11 of its potential returns per unit of risk. The Clene Inc is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 660.00 in Clene Inc on August 29, 2024 and sell it today you would lose (272.00) from holding Clene Inc or give up 41.21% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 98.4% |
| Values | Daily Returns |
Eliem Therapeutics vs. Clene Inc
Performance |
| Timeline |
| Eliem Therapeutics |
| Clene Inc |
Eliem Therapeutics and Clene Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Clene
The main advantage of trading using opposite Eliem Therapeutics and Clene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Clene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clene will offset losses from the drop in Clene's long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Clene vs. MediciNova | Clene vs. Eliem Therapeutics | Clene vs. Molecular Partners AG | Clene vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets |